Curcumin and neuroinflammation in autism: Mechanistic insights and therapeutic implications
Advanced Neurology · 2025-11-04 · 5 (3) · 025350089
DOI: 10.36922/an025350089 ↗Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impairments in social interaction and communication. According to recent research, neuroinflammation may play a role in the pathogenesis of ASD. Curcumin, the active compound in turmeric, has been demonstrated to exhibit neuroprotective, antioxidant, and anti-inflammatory properties. This review summarizes the potential mechanisms by which curcumin may influence the inflammatory pathways implicated in ASD. Curcumin can suppress nuclear factor kappa-light-chain-enhancer of activated B-cell activation, thereby reducing the levels of pro-inflammatory cytokines. In addition, it can protect mitochondrial function, upregulate antioxidant enzymes, scavenge reactive oxygen and nitrogen species, and modulate the gut–brain axis. Animal studies have shown that curcumin can improve sociability, repetitive behaviors, and enhance cognitive function in ASD models. The beneficial effects of curcumin supplementation on autism symptoms have also been documented in several small clinical trials involving children with ASD. Overall, curcumin is a natural compound with the potential to modulate neuroinflammatory pathways implicated in ASD; however, its therapeutic role remains under investigation.
EUVIMED